7.47
Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
16.79%
42.95
|
36.77 | 29.16 | 26.28 | 27.72 |
| Operating Income/Loss |
16.79%
-42.95
|
-36.77 | -29.16 | -26.28 | -27.72 |
| Nonoperating Income/Loss |
21.82%
2.2136
|
2.8315 | -1.0133 | 1.7134 | 1.8083 |
| Income/Loss From Continuing Operations Before Tax |
20.01%
-40.73
|
-33.94 | - | -24.57 | -25.91 |
| Income Tax Expense/Benefit |
0.0016
|
- | - | - | - |
| Net Income/Loss |
20.01%
-40.73
|
-33.94 | -30.17 | -24.57 | -25.91 |
| Basic Average Shares |
0.86%
57.93
|
57.43 | - | 45.72 | 45.71 |
| Diluted Average Shares |
0.86%
57.93
|
57.43 | - | 45.72 | 45.71 |
| Basic Earnings Per Share |
18.64%
-0.70
|
-0.59 | - | -0.54 | -0.57 |
| Diluted Earnings Per Share |
18.64%
-0.70
|
-0.59 | - | -0.54 | -0.57 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):